![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Author: Maimone D. Dominici R. Grimaldi L.M.E.
Publisher: Elsevier
ISSN: 0014-2999
Source: European Journal of Pharmacology, Vol.413, Iss.1, 2001-02, pp. : 11-29
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Cholinergic receptors and neurodegenerative diseases
By Gualtieri F.
Pharmaceutica Acta Helvetiae, Vol. 74, Iss. 2, 2000-03 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Chelating Agents for Neurodegenerative Diseases
Current Medicinal Chemistry, Vol. 19, Iss. 17, 2012-06 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Receptors in neurodegenerative diseases
By Froestl W.
Pharmaceutica Acta Helvetiae, Vol. 74, Iss. 2, 2000-03 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Antioxidant strategies for neurodegenerative diseases
Expert Opinion on Therapeutic Patents, Vol. 11, Iss. 4, 2001-04 ,pp. :